Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report)’s stock price fell 7% on Thursday . The company traded as low as $45.96 and last traded at $47.10. 3,519 shares changed hands during mid-day trading, a decline of 8% from the average session volume of 3,816 shares. The stock had previously closed at $50.67.
Analysts Set New Price Targets
Separately, Barclays began coverage on shares of Carl Zeiss Meditec in a research note on Tuesday, September 9th. They issued an “overweight” rating for the company. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold”.
View Our Latest Stock Report on CZMWY
Carl Zeiss Meditec Stock Up 0.8%
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- Financial Services Stocks Investing
- Why Amazon Could Be a $300 Stock Within Weeks
- Investing in the High PE Growth Stocks
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
